| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a075e31ceba3b25a3e1f4f1453ee3e2e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60 |
| filingDate |
1993-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78ddc72d42f2ce443e11c713cb25ec82 |
| publicationDate |
1993-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0572963-A2 |
| titleOfInvention |
High efficacy sclerosing solution causing no iatrogenic lesions and process to obtain this solution |
| abstract |
The invention relates to a high efficacy sclerosing solution obtained by dissolving salicylic acid and sodium carbonate or sodium salicylate to reach a concentration ranging between 3% and 12% with glycerol in bidistilled water at a 10% to 60% concentration. Process to obtain this solution. The solution is prepared either with the use of sterile equipment in an aseptic environment or autoclaved. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6989447-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9842312-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-201800001122-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9842312-A3 |
| priorityDate |
1992-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |